A 10-day microlearning course may help pharmacists decode genetic data for safer prescriptions
NCT ID NCT07735572
First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This trial tests whether a brief, Arabic-language microlearning program can improve community pharmacists' ability to use pharmacogenomic information — how a person's genes affect their response to drugs — in their daily practice. About 150 licensed pharmacists in Jordan will take the program over 10 days, covering topics like interpreting genetic test results for the blood thinner clopidogrel. Researchers will measure changes in decision-making, knowledge, and confidence immediately after the program and again four weeks later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Arabic CPIC-based pharmacogenomics microlearning program
- What this could lead to
- If effective, this program could help pharmacists worldwide better interpret genetic data to improve medication safety and effectiveness.
- What could go wrong
- This is a small, single-country trial with a short follow-up. Results may not apply to other settings or translate into lasting changes in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOGENOMICS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Petra University
Amman, Amman Governorate, Jordan